| Daniel J Kvale, PAC | |
|
105 W Main St, Bison, SD 57620-0003 | |
| (605) 244-5206 | |
| (605) 244-5208 |
| Full Name | Daniel J Kvale |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 21 Years |
| Location | 105 W Main St, Bison, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750356465 | NPI | - | NPPES |
| 5350300 | Medicaid | SD | |
| 42507 | Other | SD | MED B |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0549 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera Dells Area Hospital - Cah | Dell rapids, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
News Archive
Health reform needs to be championed by health leaders, responsive to community needs and securely funded, to be sustained and benefit the health of Australians according to a new research published in the Medical Journal of Australia.
Cyberonics, Inc., a global leader in epilepsy management, today announced results for the quarter ended January 28, 2011.
Takeda Pharmaceuticals North America, Inc. announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than esomeprazole.
Scientists in Belfast have identified a gene which could predict whether women with breast cancer will respond to treatment with tamoxifen, according to findings published today in Cancer Research.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel J Kvale, PAC Po Box 427, Bison, SD 57620-0427 Ph: (605) 244-5206 | Daniel J Kvale, PAC 105 W Main St, Bison, SD 57620-0003 Ph: (605) 244-5206 |
News Archive
Health reform needs to be championed by health leaders, responsive to community needs and securely funded, to be sustained and benefit the health of Australians according to a new research published in the Medical Journal of Australia.
Cyberonics, Inc., a global leader in epilepsy management, today announced results for the quarter ended January 28, 2011.
Takeda Pharmaceuticals North America, Inc. announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than esomeprazole.
Scientists in Belfast have identified a gene which could predict whether women with breast cancer will respond to treatment with tamoxifen, according to findings published today in Cancer Research.
› Verified 5 days ago